Search Results
Mar 30, 2026, 10:08 ET California Design Den Selected as a Good Housekeeping 2026 Bedding Award Winner
Housekeeping Institute Textiles Lab tested hundreds of bedding products to find Good Housekeeping's 2026 Bedding Award winners. Using specialized equipment, they conducted evaluations to assess factors like fabric strength, pilling resistance, shrinkage after laundering, and more. Lab experts enlisted more than
More news about: California Design Den
Mar 30, 2026, 10:00 ET Sanyou Milestone | Recognized as a "Shanghai Municipal Enterprise Technology Center," Further Validating for Innovation Excellence
fundamentally addressing the key challenges at the source of innovative drug development.Powered by its AI-STAL and supported by an integrated wet-lab/dry-lab R&D platform, Sanyou provides comprehensive, one-stop solutions for innovative drug discovery, with a particular focus on molecular discovery
More news about: Sanyou Bio
Mar 30, 2026, 09:53 ET Harbour BioMed Reports Full Year 2025 Financial Results: Sustained Global Collaboration Underpins Long-Term Growth
innovative, multi-faceted framework that combines R&D collaboration, equity investment, and the establishment of the Harbour BioMed-AstraZeneca Innovation Lab.Together, these collaborations underscore Harbour BioMed's evolving platform-driven partnership model, enabling the Company to accelerate global
More news about: Harbour BioMed
Mar 30, 2026, 09:21 ET Nuvia Dental Implant Center Featured on Advancements with Ted Danson
crafted overnight in Nuvia's own in-house lab, which is located at each of their nationwide locations.The Technology Making It PossibleThe on-site filming captured Nuvia's full clinical workflow — from the diagnostic process through lab coordination and delivery. The feature highlights
More news about: Nuvia Dental Implant Center
Mar 30, 2026, 09:18 ET Konica Minolta bizhub i-Series Receives Keypoint Intelligence Security Validation Seal for Device Penetration
Keypoint Intelligence for independent hands-on testing, lab data, and extensive market research to drive their product and sales success. Keypoint Intelligence has been recognized as the industry's most trusted
More news about: Keypoint Intelligence
Mar 30, 2026, 09:18 ET Konica Minolta bizhub i-Series Receives Keypoint Intelligence Security Validation Seal for Device Penetration
Keypoint Intelligence for independent hands-on testing, lab data, and extensive market research to drive their product and sales success. Keypoint Intelligence has been recognized as the industry's most trusted
More news about: Keypoint Intelligence
Mar 30, 2026, 09:09 ET Biointelli Launches Scientific Signal Intelligence™ -- A New Category That Predicts Life Science Demand Before It Exists in Your CRM
draws directly from the scientific record — including NIH and NSF grant awards, industry funding, PubMed publication velocity, USPTO patent filings, lab hiring activity, clinical trial expansion, citation network growth, and conference abstract activity. Each signal is measured as a rate of change — a
More news about: Biointelli Corporation
Mar 30, 2026, 09:05 ET Tigermed Announces 2025 Annual Results
reporting period, segment revenue generated from Clinical Trial Solutions reached RMB 3,267 million, and segment revenue generated from Clinical-related and Lab Services reached RMB 3,566 million.During the reporting period, China revenue was RMB 3,705 million, accounting for 54% of total revenue, while
More news about: Tigermed
Mar 30, 2026, 09:00 ET K9s For Warriors Marks 15 Years of Saving Lives at Both Ends of the Leash with Launch of Operation: Reach Every Warrior
and/or military sexual trauma — at no financial cost to the Veteran. Backed by groundbreaking scientific research from the University of Arizona's OHAIRE Lab, the program demonstrates how Service Dogs can help mitigate symptoms of PTSD while simultaneously restoring confidence and independence. Founded in
More news about: K9s For Warriors
Mar 30, 2026, 09:00 ET Roche receives FDA 510(k) clearance for cobas® c703 and cobas® ISE neo, next-generation analytical units enhancing efficiency and capability for laboratories
cobas® c 703 and cobas® ISE neo. As part of the scalable and modular cobas® pro integrated solutions, these additions deliver advanced lab-automation capabilities designed to help address some of today's most pressing laboratory challenges, including staff shortages, limited space and growing
More news about: Roche Diagnostics
Mar 30, 2026, 08:56 ET Tigermed Announces 2025 Annual Results
reporting period, segment revenue generated from Clinical Trial Solutions reached RMB 3,267 million, and segment revenue generated from Clinical-related and Lab Services reached RMB 3,566 million.During the reporting period, China revenue was RMB 3,705 million, accounting for 54% of total revenue, while
More news about: Tigermed
Mar 30, 2026, 08:38 ET Catalyst Precision Health Launches the First Longevity Service for Men to Combine In-Home Lab Testing, Physician House Calls, and Continuous Personalized Care
Catalyst is the first longevity service for men to bring in-home lab testing, physician house calls, and on-demand access to your doctor together under one model, helping men stay healthier longer through personalized protocols with precise dosing tailored to their biology.NEW
More news about: Catalyst Precision Health
Mar 30, 2026, 07:01 ET DENARIUS METALS ANNOUNCES POSITIVE PEA RESULTS FOR ITS 100%-OWNED ZANCUDO PROJECT IN COLOMBIA
1,150,000Owner's costs, including lab and other site infrastructure450,000
More news about: Denarius Metals Corp.
Mar 30, 2026, 04:00 ET China's first overseas full-tab production line: Highstar's Malaysia Tabless base officially starts production
CeilingsThe highlight was the debut of the INR21700-50PS, a 5.0Ah all-around tabless cell, successfully pushing tabless technology from the lab into intelligent mass production. Achieving 3 technological breakthroughs, 4 core highlights, and serving 5 major applications, it features bottom-layer
More news about: Highstar
Mar 30, 2026, 03:15 ET Lunit, CellCarta Announce Strategic Collaboration to Accelerate AI-Enabled Digital Pathology for Companion Diagnostic Programs
capabilities, and regulated laboratory infrastructure. Together, the companies aim to support single-site CDx development and launch pathways, coupled with a lab developed test (LDT) based support strategy for global trials, while remaining complementary to established IVD manufacturers and platform partners.
More news about: Lunit
Mar 29, 2026, 10:00 ET Landmark ALL-RISE® Trial Results Presented at ACC.26: CathWorks FFRangio Demonstrates Similar Clinical Outcomes to Invasive Wire-based Physiology Assessment
acute kidney injury or procedure-related adverse events.The FFRangio group demonstrated improved resource utilization in the catheterization lab with reduced radiation exposure and less use of contrast medium than the pressure wire group. Despite having a slightly higher rate of percutaneous coronary
More news about: CathWorks
Mar 29, 2026, 10:00 ET Landmark ALL-RISE® Trial Results Presented at ACC.26: CathWorks FFRangio Demonstrates Similar Clinical Outcomes to Invasive Wire-based Physiology Assessment
acute kidney injury or procedure-related adverse events.The FFRangio group demonstrated improved resource utilization in the catheterization lab with reduced radiation exposure and less use of contrast medium than the pressure wire group. Despite having a slightly higher rate of percutaneous coronary
More news about: CathWorks
Mar 28, 2026, 16:45 ET REPATHA® CUTS RISK OF FIRST MAJOR CARDIOVASCULAR EVENTS BY 31% IN HIGH-RISK PATIENTS WITHOUT KNOWN SIGNIFICANT ATHEROSCLEROSIS
80 mg/dL; and treated with highest tolerated dose of statin and/or ezetimibe. The median baseline LDL-C was 122 mg/dL (IQR, 104-149 mg/dL) on local lab testing. Participants were randomized to receive Repatha or placebo in addition to optimized lipid-lowering therapy and were followed for a median of
More news about: Amgen
Mar 27, 2026, 15:51 ET Transform 2026 Concludes with 4,000+ Leaders Defining the Human + AI Equation
emerging innovation, with Ali Al Jabry, Co-Founder & CEO, Kwema named 2026 winner. EXP + Learning Lab: Interactive, practice-based environments, including the Learning Lab by Deloitte and expanded EXP programming on the social and global forces reshaping how we live and work. Expanded
More news about: Transform
Mar 27, 2026, 09:30 ET How Decentralized AI is Unlocking Value in Cardiac Diagnostics
study assessing the real-world impact of AI-guided CT-based pre-procedural planning on clinical strategy and physician confidence in the catheterization lab."These milestones reflect tremendous progress toward Heartflow's goal of transforming coronary artery disease from the world's leading
More news about: USA News Group
Mar 27, 2026, 09:15 ET Scalable Biotech Manufacturing Unlocks a $14B Market
the FDA just stepped in with new flexibility measures for cell and gene therapies[2]. By easing manufacturing requirements from the lab to commercial launch, regulators are accelerating the timeline for life-saving product approvals. This historic shift toward scalable bioproduction infrastructure
More news about: USA News Group
Mar 27, 2026, 08:39 ET Live Conscious® Launches Clinical Hair Growth+ Supplement Featuring Serevelle™, Clinically Shown to Increase Hair Density in 90 Days*
commitment to efficacy, utilizing clinically relevant doses in every product. We start with premium ingredient sourcing and independent third-party lab verification to ensure professional-grade integrity. Backed by an industry-leading 365-day satisfaction guarantee, Live Conscious empowers people to
More news about: Live Conscious
Mar 27, 2026, 06:45 ET Neutrogena®, Aveeno® and Rogaine® Release New Dermatology Research and Clinical Skincare Innovations on Healthy Aging, Moisturization, Sun Protection and Acne
giveaways to support their growth in dermatology practice and apply for scholarship opportunities to attend George Washington University's second annual Lab to Label conference.For more information on how Neutrogena®, Aveeno® and Rogaine® are showing up at AAD 2026, or how the company aims to transform
More news about: Kenvue Inc.
Mar 27, 2026, 06:20 ET Shreehas Tambe übernimmt zum 1. April 2026 die Rolle des Executive Officer und Managing Director bei Biocon Limited
Forschungs- und Entwicklungspipeline mit mehr als 20 Biosimilar- Wirkstoffen sowie GLP-1- Peptiden und weiteren komplexen Generika.Mit seinem „Lab–to–Patient"-Modell setzt Biocon seine Expertise entlang der gesamten Wertschöpfungskette ein und integriert Forschung und Entwicklung sowie Produktion und Vertrieb,
More news about: Biocon
Mar 27, 2026, 05:38 ET Shreehas Tambe Appointed CEO & Managing Director of Biocon Limited, Effective April 1, 2026
billion in 2025. He led the transformational acquisition of the biosimilars business and oversaw its rapid consolidation, creating a fully integrated, lab-to-patient biosimilars enterprise.Previously, Shreehas served as Chief Operating Officer and later Deputy CEO of Biocon Biologics, driving enterprise-wide
More news about: Biocon